New Findings Support the Adoption of Fast Vitrification and Fast Warming Protocols – RBMO
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn about a paper by Christopher K. Arkfeld et al.:
”New findings add to the growing body of literature supporting the adoption of fast vitrification and fast warming protocols.
This new paper from Christopher Ke Arkfeld, Stylianos Vagios, Evelyn Minis, Victoria Fitz, Victoria Jiang, and Charles Bormann presents data from the first US-based study to analyse and report on the pregnancy outcomes from fast vitrification protocols in the setting of both standard warming and fast warming protocols.
Previous studies have supported fast warming compared with standard warming techniques, noting no impact on pregnancy outcome, and of note, Liebermann et al. (2024) did utilize a fast vitrification protocol of 7 min when comparing single-step warming and standard warming techniques.
More recently, studies have demonstrated comparable reproductive potential following the adoption of both fast vitrification and fast warming protocols; however, the specific impacts of exposure to equilibrium solution and ploidy status warranted further investigation (Turhan et al., 2026).
Arkfeld and colleagues report no significant differences in pregnancy, miscarriage or live birth rates between fast vitrification and standard vitrification, regardless of warming technique or ploidy status.”
Title: Impact of combining fast vitrification and fast warming protocols on live birth outcomes
Authors: Christopher Ke Arkfeld, Stylianos Vagios, Evelyn Minis, Victoria Fitz, Victoria Jiang, and Charles Bormann
You can read the Full Article in RBMO.
Other articles featuring Reproductive BioMedicine Online on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic